Chromosomal Microarray Testing
In Patients with Development Delay, Autism or other Congenital Anomalies
Conclusions
September 2011
We hope this has been a helpful introduction to microarray testing which is now recommended as a first-line test for individuals with developmental delay or intellectual disability, multiple congenital anomalies, or autism spectrum disorder. Our new array platform contains 180,000 oligonucleotide probes for genome-wide resolution of approximately 100 kilobases and 20 kilobases in targeted regions. And again comprehensive genetic counseling is recommended.
Conclusions |
Jump to section:
- Introduction
- History of Cytogenetic Testing
- History of Cytogenetic Testing
- Chromosomal Microarray Testing
- Chromosomal Microarray Data
- 180K Oligonucleotide Microarray
- Limitations of Chromosomal Microarray
- Human Copy Number Variation (CNV)
- Interpretation of Results
- When to Order a Microarray?
- Additional ACMG Recommendations
- Pretest Counseling
- Pretest Counseling
- Post-Test Follow-Up
- Post-Test Follow-Up
- Post-Test Follow-Up
- The International Standards for Cytogenomic Arrays (ISCA) Consortium
- The ISCA Consortium
- Providing Clinical Information
- Conclusions
- Mayo Clinic Cytogenetics Laboratory
- Questions?


